Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein

Increased Coronary Heart Disease Risk Determined by High High-Density Lipoprotein Cholesterol and C-Reactive Protein: Modulation by Variation in the CETP Gene

(2010) Robin P.F. Dullaart   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Inflammation reduces HDL protection against primary cardiac risk

(2010) James P. Corsetti et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: Possible attenuation of cardioprotection associated with high HDL cholesterol

(2009) Robin P.F. Dullaart et al.   ATHEROSCLEROSIS

Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices

(2009) J. H. Contois et al.   CLINICAL CHEMISTRY

Targets for LDL-lowering therapy

(2009) Allan Sniderman   CURRENT OPINION IN LIPIDOLOGY

The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls

(2009) S. Parish et al.   EUROPEAN HEART JOURNAL

Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein

(2009) Paul JWH Kappelle et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Albuminuria Assessed From First-Morning-Void Urine Samples Versus 24-Hour Urine Collections as a Predictor of Cardiovascular Morbidity and Mortality

(2008) H. J. Lambers Heerspink et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment

(2008) John J.P. Kastelein et al.   CIRCULATION

High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus

(2008) Robin P. F. Dullaart et al.   CLINICAL ENDOCRINOLOGY

High-Density Lipoprotein Cholesterol, High-Density Lipoprotein Particle Size, and Apolipoprotein A-I: Significance for Cardiovascular Risk

(2008) Wim A. van der Steeg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Statin Therapy Alters the Relationship Between Apolipoprotein B and Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol Targets in High-Risk Patients

(2008) Christie M. Ballantyne et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lipoprotein Management in Patients With Cardiometabolic Risk

(2008) John D. Brunzell et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

(2008) Matthew J McQueen et al.   LANCET

Association of C-Reactive Protein and Microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004)

(2007) Abhijit V. Kshirsagar et al.   AMERICAN JOURNAL OF CARDIOLOGY

Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atheroslcerosis (MESA)

(2007) Ian H. de Boer et al.   ATHEROSCLEROSIS